US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Shield Therapeutics PLC

0.0901

0.0000

Volume:- -

Turnover:- -

Market Cap:95.67M

PE:-2.94

High:0.0901

Open:0.0901

Low:0.0901

Close:0.0901

52wk High:0.1277

52wk Low:0.0331

Shares:1.06B

Float Shares:1.04B

Volume Ratio:2.62

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.0306

EPS(LYR):-0.0306

ROE:-396.35%

ROA:-16.77%

PB:-6.44

PE(LYR):-2.94

Loading ...

Overview Company News Filings

Company Profile

Company Name:

Shield Therapeutics PLC

Exchange:

OTCQB

Establishment Date:

2008

Employees:

63

Office Location:

Northern Design Centre,Baltic Business Quarter,Gateshead,Tyne and Wear,United Kingdom

Website:

- -

Zip Code:

NE8 3DF

Phone:

44 1915 118 500

Fax:

- -

Introduction:

Shield Therapeutics plc, a specialty pharmaceutical company, focuses on commercialization of pharmaceuticals to treat unmet medical needs. Its lead product is Accrufer/Feraccru, a non-salt based oral therapy for adults to treat the iron deficiency with or without anemia. Shield Therapeutics plc was founded in 2008 and is based in Gateshead, the United Kingdom.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/SHIEF/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SHIEF","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SHIEF\",,,,,undefined,":{"symbol":"SHIEF","market":"US","secType":"STK","nameCN":"Shield Therapeutics PLC","latestPrice":0.0901,"timestamp":1764968400000,"preClose":0.0901,"halted":0,"volume":0,"delay":15,"floatShares":1041690484,"shares":1061802812,"eps":-0.030628,"marketStatus":"Market Closed","change":0,"latestTime":"12-05 16:00:00 EST Delay","open":0.0901,"high":0.0901,"low":0.0901,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-0.030628,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1765184400000},"marketStatusCode":7,"adr":0,"exchange":"OTCQB","adjPreClose":0.0901,"volumeRatio":2.617801059112963},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SHIEF\",,,,,undefined,":{"symbol":"SHIEF","floatShares":1041690484,"roa":"-16.77%","roe":"-396.35%","lyrEps":-0.030628,"volumeRatio":2.617801059112963,"shares":1061802812,"dividePrice":0,"high":0.0901,"amplitude":0,"preClose":0.0901,"low":0.0901,"week52Low":0.0331,"pbRate":"-6.44","psRate":"2.31","week52High":0.1277,"institutionHeld":0,"latestPrice":0.0901,"eps":-0.030628,"divideRate":0,"volume":0,"delay":15,"ttmEps":-0.030628,"open":0.0901,"prevYearClose":0.0345,"prevWeekClose":0.0901,"prevMonthClose":0.0901,"prevQuarterClose":0.1016,"fiveDayClose":0.0901,"twentyDayClose":0.0983,"sixtyDayClose":0.1169},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SHIEF\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-09-04","symbol":"SHIEF","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1725422400000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2024-04-30","symbol":"SHIEF","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1714449600000,"reportTimeType":"","actualEps":null},{"market":"US","date":"2022-06-30","symbol":"SHIEF","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1656561600000,"reportTimeType":"","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SHIEF\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SHIEF\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.5,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.5,"analysts":2,"updateTime":1759726800000},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":115221091,"yearFounded":2008,"employeeNum":63,"address":"Northern Design Centre,Baltic Business Quarter,Gateshead,Tyne and Wear,United Kingdom","zipCode":"NE8 3DF","officePhone":"44 1915 118 500"},"stockCompanyDetail":{"stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"ytd","weight":0}],"description":"Shield Therapeutics plc, a specialty pharmaceutical company, focuses on commercialization of pharmaceuticals to treat unmet medical needs. Its lead product is Accrufer/Feraccru, a non-salt based oral therapy for adults to treat the iron deficiency with or without anemia. Shield Therapeutics plc was founded in 2008 and is based in Gateshead, the United Kingdom.","exchange":"OTCQB","name":"Shield Therapeutics PLC","nameEN":"Shield Therapeutics PLC"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"SHIEF\",market:\"US\",,,undefined,":null}}